Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Mindfulness program added to Weight-Loss drugs shows promise in small trial

NCT ID NCT07649759

Symptom relief Sponsor: Bern University of Applied Sciences Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a 16-week mindfulness-based nutrition group program is feasible and acceptable for adults with obesity who are already taking GLP-1 medications. Forty participants will either join the group program plus usual care or receive usual care alone. The program includes mindful eating exercises, journaling, and peer support. The goal is to see if people find it helpful and stick with it, not to test a new drug.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
mindfulness-based nutritional group therapy (behavioral intervention)
What this could lead to
If successful, this program could offer a practical, non-drug way to improve eating habits and emotional well-being for people already on GLP-1 medications for obesity.
What could go wrong
This is a small, early feasibility study with only 40 participants, so results may not apply widely. It does not test a new drug, and the main goal is to see if the program is acceptable, not whether it causes weight loss.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2026

Expected to finish

Aug 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria * Adults aged ≥18 * Use of GLP-1-RAs for ≥ 4 months * Ability to provide informed consent * Sufficient German language proficiency to participate in group sessions and complete questionnaires * Willingness and ability to participate in a 16-week program and attend follow-up assessments Exclusion Criteria: * Pregnant or lactating women * Diagnosed substance use disorders (e.g., alcohol) * Diagnosed severe psychiatric disorders (e.g., psychosis, acute major depression, binge-eating-disorder) * Medical contraindications that prevent participation in behavioral interventions (e.g., unstable chronic disease) * Current participation in another behavioral or weight-related intervention study * Cognitive impairment or language barriers that prevent meaningful participation

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Emotional eating behaviour are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Feeding Behavior Obesity obesity disorder Overweight Self-Control Social Stigma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Emotional eating behaviour Mindful eating intervention Obesity & overweight

Contacts and locations

Locations

  • Bern University of Applied Sciences (BFH), Department of Health Professions, Division of Nutrition and Dietetics

    Bern, 3006, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.